Dennis Mauricio

Integrated mutational landscape analysis of uterine leiomyosarcomas

Jungmin Choi, Aránzazu Manzano, Weilai Dong et al. · Proceedings of the National Academy of Sciences · 2021 · 118 citations · Full text

Medicine, Genetics, Oncology +17

A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability

Stefania Bellone, Dana M. Roque, Eric R. Siegel et al. · Cancer · 2021 · 77 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu

Joan Tymon‐Rosario, Eric R. Siegel, Stefania Bellone et al. · Gynecologic Oncology · 2021 · 28 citations · Full text

Medicine, Gynecology, Oncology +14

Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate with topoisomerase I inhibitor payload, shows antitumor activity in uterine and ovarian carcinosarcoma with HER2/neu expression

Dennis Mauricio, Stefania Bellone, Levent Mutlu et al. · Gynecologic Oncology · 2023 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17

DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo

Joan Tymon‐Rosario, Elena Bonazzoli, Stefania Bellone et al. · Gynecologic Oncology · 2021 · 18 citations · Full text

Medicine, Oncology, Pharmacology +12